A Paxil, Pexeva CEP of the European Pharmacopoeia monograph is often referred to as a Paxil, Pexeva Certificate of Suitability (COS). The purpose of a Paxil, Pexeva CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Paxil, Pexeva EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Paxil, Pexeva to their clients by showing that a Paxil, Pexeva CEP has been issued for it. The manufacturer submits a Paxil, Pexeva CEP (COS) as part of the market authorization procedure, and it takes on the role of a Paxil, Pexeva CEP holder for the record. Additionally, the data presented in the Paxil, Pexeva CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Paxil, Pexeva DMF.
A Paxil, Pexeva CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Paxil, Pexeva CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Paxil, Pexeva suppliers with CEP (COS) on PharmaCompass.